Quintara Biosciences Expands Lab Operations in Boston Area for Enhanced Services

Quintara Biosciences, a prominent name in the field of genomics and molecular biology, has announced a significant move to enhance its service capabilities. The company has relocated its lab from the Boston area to Watertown, Massachusetts, effective June 1, 2026. This relocation is a strategic response to the growing demand for their sequencing services and is expected to bolster Quintara's operational readiness for future challenges.

With over 20 years of sequencing experience, Quintara operates five service sites and maintains a robust network of over 1,000 sample drop boxes across the nation. The relocation to Watertown positions the lab amidst the leading life science corridor in Greater Boston, reinforcing the company’s commitment to providing timely and reliable services to its clients. In particular, the new lab will enable Quintara to support its clients with overnight turnaround on most sequencing services and offer same-day local sample pickups, including weekend services, which are crucial for high-volume molecular biology workflows.

Daniel Wang, CEO of Quintara Biosciences, emphasized the importance of the Boston area for the company, stating, "Greater Boston has long been one of Quintara's core regions, and it will remain a major focus for us." The emphasis on services such as whole plasmid sequencing, amplicon sequencing, and RNA sequencing reflects the fast-paced research environment in the region, where speed, consistency, and reliability are crucial. The Watertown facility aims to strengthen these aspects through better cost efficiency and dependable delivery capabilities.

The transition to the new Watertown lab was executed as a phased operational project to maintain uninterrupted service delivery. Eric Lu, CTO of Quintara, explained, "Relocating an active sequencing laboratory requires careful control over sample handling, instrument readiness, and turnaround commitments." This careful planning ensured that sample pickups and service deliveries continued smoothly during the move.

The newly established lab in Watertown benefits from expanded space with clearly defined functional zones for laboratories, administrative tasks, and collaborative efforts. These improvements facilitate organized sample intake processes, timely handoffs between teams, enhanced storage solutions, and better resource planning. The clear demarcations in the new facility will aid in maintaining traceability and consistent execution, crucial for delivering reliable data as demand continues to rise.

Quintara Biosciences prides itself on being a nationwide provider of sequencing, cloning, and gene synthesis solutions tailored for academic, biotech, and pharmaceutical sectors. With additional labs located in cities such as San Francisco, Los Angeles, San Diego, and Houston, the company aims to deliver fast, reliable, and cost-effective services that cater to the unique needs of its diverse clientele. The decision to expand in Watertown exemplifies Quintara's commitment to scaling its operations while overcoming the challenges posed by an ever-evolving market.

In conclusion, with the relocation of its Boston area lab, Quintara Biosciences is not only improving its operational capabilities but also reinforcing its dedication to excellence in sequencing and molecular biology services. This transformation aims to ensure that Quintara remains at the forefront of the industry, providing its partners with the high-quality services they need for their research and clinical endeavors. For more information on Quintara's services, visit www.quintarabio.com.